Buy Epithalon Peptide 10 mg Online | ≥99% Purity | Certificate of Analysis Included

Buy Epithalon Peptide 10 mg Online from SourceTides — the research-grade tetrapeptide (Ala-Glu-Asp-Gly; AEDG; CAS 307297-39-8) supplied at ≥99% HPLC-verified purity with a full Certificate of Analysis. Every vial is lyophilised under ISO-grade conditions, independently endotoxin-tested (LAL <1 EU/mg), and dispatched on dry-ice cold chain. Epithalon is intended exclusively for in-vitro laboratory and preclinical research use only and is not approved for human consumption.

Epithalon 10 mg Technical Specifications

What Is Epithalon Peptide?

Epithalon (also spelled Epitalon or Epithalone) is a synthetic tetrapeptide comprising the four-amino-acid sequence Alanine-Glutamic acid-Aspartic acid-Glycine (AEDG). It was originally identified by Professor Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology during the late 1980s and early 1990s. The peptide was engineered as the bioactive, chemically defined analog of Epithalamin — a crude polypeptide extract obtained from bovine pineal glands that had previously demonstrated geroprotective properties in Soviet-era animal studies.

The central scientific rationale for Epithalon research lies in its capacity to activate telomerase — the enzyme responsible for maintaining and elongating telomeres, the protective nucleotide repeats capping chromosomal ends. Telomere length is a recognised biomarker of biological age: human somatic cells lose approximately 50–70 base pairs of telomeric DNA per division, progressively approaching the Hayflick limit and entering replicative senescence. By upregulating hTERT (the catalytic subunit of telomerase), Epithalon has been shown in multiple in-vitro models to extend telomere length beyond this natural boundary — a finding that has catalysed its widespread use as a model compound in aging biology research.

Beyond telomere biology, the peptide’s interactions with the pineal gland distinguish it from other geroprotective compounds. The pineal gland’s melatonin output declines significantly with age, disrupting circadian rhythms and reducing systemic antioxidant defence. Epithalon appears to stimulate pineal cells to restore melatonin synthesis rhythms observed in younger subjects. This dual mechanism — cellular lifespan extension at the chromosomal level combined with restoration of neuroendocrine circadian architecture — makes Epithalon among the most mechanistically complex tetrapeptides currently studied in preclinical gerontology.

A landmark 2025 study published in the journal Biogerontology (Al-Dulaimi et al., 2025; PMC full text) independently confirmed, using qPCR and immunofluorescence, that Epitalon increases telomere length in normal human cell lines through hTERT upregulation, providing the first significant Western-laboratory replication of Khavinson’s foundational 2003 findings. Researchers studying cellular senescence, neuroendocrine aging, oxidative stress biology, or longevity pharmacology will find Epithalon 10 mg from SourceTides an essential reference compound.

Mechanism of Action: How Epithalon Works at the Molecular Level

Epithalon’s biological activity is mediated through at least four distinct and interconnected molecular pathways. Each pathway has been characterised across in-vitro cell culture experiments, in-vivo rodent and primate studies, and in-silico modelling, providing a layered mechanistic picture that continues to evolve as independent laboratories replicate and extend the original Russian findings.

1. Telomerase Activation via hTERT Upregulation

The most extensively documented mechanism of Epithalon action is its capacity to upregulate expression of hTERT (human Telomerase Reverse Transcriptase) — the rate-limiting catalytic subunit of the telomerase holoenzyme. In telomerase-negative human fetal fibroblasts, Epithalon treatment induced hTERT mRNA expression de novo, thereby reactivating telomerase enzymatic activity in cells that had naturally silenced it as part of differentiation. This was confirmed by the TRAP (Telomere Repeat Amplification Protocol) assay and directly correlated with measurable telomere elongation. In the 2025 Al-Dulaimi et al. study, dose-dependent telomere length extension was quantified using both qPCR and immunofluorescence microscopy in normal human fibroblast (IBR.3) and epithelial cell (HMEC) lines treated for three weeks at 1.0 µg/mL concentrations. The data confirmed that Epithalon-treated cells exceeded replicative limits achievable in untreated controls — the molecular basis of what Khavinson originally described as “extension of the Hayflick limit.” Mechanistically, Epithalon’s tetrapeptide structure appears to modulate transcription factor access at the hTERT promoter, potentially by interacting with histone H1 proteins (H1.3 and H1.6) to remodel chromatin architecture and render the hTERT gene locus accessible. See: Al-Dulaimi et al. 2025, Biogerontology.

2. Epigenetic Modulation — Methylated DNA Binding and Gene Expression

Epithalon has been demonstrated to bind preferentially to methylated cytosine residues in DNA — a property with broad epigenetic implications. Hypermethylation of gene promoters is a well-established mechanism of gene silencing associated with aging and cellular senescence. By interacting with methylated chromatin regions, Epithalon may facilitate de-repression of genes whose silencing contributes to the aging phenotype, including those encoding antioxidant enzymes, DNA repair machinery, and neuroendocrine regulators. A 2020 peer-reviewed study published in Molecules (Khavinson et al., PMID: 32019204; PMC full text) demonstrated that AEDG peptide stimulates gene expression and protein synthesis during neurogenesis in cellular models, proposing epigenetic chromatin remodelling as the mechanistic underpinning. This epigenetic axis of action positions Epithalon among a growing class of “epigenetic bioregulator” research peptides relevant to aging genomics laboratories.

3. Pineal Gland Stimulation and Melatonin Pathway Restoration

Independent of its nuclear epigenetic activities, Epithalon exerts documented neuroendocrine effects through stimulation of pineal gland melatonin synthesis. The pineal gland’s nocturnal melatonin output declines progressively with age, driven by degenerative changes in pinealocyte function, reduced sensitivity to sympathetic signals, and decreased N-acetyltransferase activity. In a landmark primate study using aged rhesus macaques (Khavinson et al., 2001; PubMed PMID: 11524632), Epithalon administration significantly stimulated evening melatonin synthesis and restored the circadian amplitude of both melatonin and cortisol secretion curves toward patterns characteristic of younger animals. Melatonin’s downstream effects are wide-ranging: as the primary endogenous ligand for MT1/MT2 receptors in the suprachiasmatic nucleus and peripheral tissues, melatonin coordinates circadian gene expression (BMAL1, CLOCK, PER1/2), antioxidant enzyme transcription (catalase, superoxide dismutase, glutathione peroxidase), and immune cell function. Restoration of melatonin circadian amplitude by Epithalon therefore creates a cascade of systemic regulatory corrections extending well beyond simple sleep modulation. This pathway also connects Epithalon to research on melatonin deficiency, jet-lag biology, shift-work disorders, and age-related immunosenescence.

4. Antioxidant Defence Enhancement and Oxidative Stress Reduction

A fourth mechanistic axis involves direct and indirect enhancement of antioxidant defence systems. Animal studies have demonstrated that Epithalon — and its parent extract Epithalamin — reduce markers of lipid peroxidation (measured as TBARS/MDA), decrease reactive oxygen species (ROS) load in multiple tissue compartments, and upregulate endogenous antioxidant enzymes including superoxide dismutase (SOD) and catalase in aged rodents. These antioxidant effects are partially attributable to the restoration of melatonin levels (melatonin itself is a potent direct ROS scavenger and indirect inducer of antioxidant gene expression). However, in-vitro cell culture studies demonstrate antioxidant activity that is not fully explained by melatonin alone, suggesting direct peptide-mediated effects on oxidative stress pathways. From a research standpoint, Epithalon’s antioxidant properties make it a relevant compound for studies of mitochondrial dysfunction, oxidative DNA damage, and the role of ROS in driving telomere attrition — a topic of growing interest given evidence that oxidative stress accelerates telomere shortening independently of the replication-based end-problem.

Epithalon Research Evidence Summary

Epithalon and Telomere Biology: The Strongest Evidence Domain

Telomere maintenance is the primary research domain in which Epithalon has accumulated the most mechanistically rigorous and independently replicated evidence. Understanding the depth and limitations of this evidence is essential for designing valid research protocols.

The Foundational 2003 Studies

Khavinson, Bondarev, and Butyugov (2003) published the first demonstration that Epithalon could induce telomerase activity in human somatic cells — cells in which telomerase is normally silenced following developmental differentiation. Using human fetal fibroblast (602/17) and adult lung fibroblast cultures alongside telomerase-positive HeLa cells as comparators, the investigators applied Epithalon and assessed telomerase activity via the TRAP assay alongside telomere length measurement. Results showed: (1) de novo induction of hTERT mRNA expression in fibroblasts that had no detectable telomerase activity at baseline; (2) upregulation of telomerase enzymatic activity confirmed by TRAP; and (3) measurable telomere length extension in treated cultures compared to untreated controls. Critically, Epithalon-treated fibroblasts continued dividing beyond the Hayflick limit — the canonical maximum number of somatic cell divisions imposed by progressive telomere shortening — providing the first evidence that Epithalon could functionally extend cellular replicative lifespan at the molecular level.

The 2025 Independent Western Replication

For over two decades, the telomere/telomerase data for Epithalon rested almost entirely on work from Khavinson’s St. Petersburg group — a significant limitation noted by multiple independent reviewers. This changed significantly in 2025 when Al-Dulaimi and colleagues published a study in Biogerontology (Springer; DOI: 10.1007/s10522-025-10315-x) representing the first major Western-laboratory replication using modern molecular biology methodology. The study employed normal human fibroblast (IBR.3) and mammary epithelial (HMEC) cells alongside breast cancer lines (21NT and BT474), treating with 0.1–1.0 µg/mL Epithalon for 3–21 days. Key findings confirmed by qPCR and immunofluorescence included: dose-dependent hTERT mRNA upregulation in normal cells; corresponding increases in telomere length measurable at the single-cell level; and a mechanistically distinct pattern in cancer cells, where Epithalon downregulated telomerase while activating the Alternative Lengthening of Telomeres (ALT) pathway — a finding with significant implications for cancer biology research. The proposed mechanism for the differential cancer-cell effect involves Epithalon’s binding to histone H1 (H1.3 and H1.6), which in turn upregulates H19 (a long non-coding RNA known to suppress telomerase), thereby redirecting telomere maintenance from TERT-dependent to ALT-dependent mechanisms. This differential mechanism is an active area of investigation and provides a compelling framework for studying the intersection of epigenetics, telomere biology, and cancer cell biology using Epithalon as a molecular probe.

Lifespan Extension Data in Animal Models

Multiple independent preclinical studies — primarily by Anisimov and colleagues — demonstrated significant lifespan extension in both rodent and invertebrate models. In mice, Epithalamin (the parent extract) and synthetic Epithalon extended mean lifespan by 13–25% in some studies, with parallel reductions in spontaneous tumour incidence. In Drosophila melanogaster models, similar lifespan extension was observed alongside reductions in free radical oxidation markers (Anisimov et al., 2001). While none of these animal studies have been independently replicated outside Russian-affiliated laboratories — a limitation clearly acknowledged in the scientific community — the mechanistic consistency across species (rodents, primates, invertebrates) and the new 2025 in-vitro human cell data lend increasing credibility to the foundational hypothesis that telomerase-mediated telomere maintenance is the primary molecular mechanism underlying the observed lifespan effects.

What Research Is Epithalon Most Relevant For?

Epithalon Pharmacokinetics for Research Design

Epithalon Side Effects and Adverse Events: Research Safety Profile

SourceTides Quality Control Epithalon 10 mg

When you buy Epithalon Peptide 10 mg online from SourceTides, every batch passes a multi-stage quality control process before release. Our commitment to analytical rigour reflects the standards required for reproducible preclinical research.

Epithalon Regulatory Status by Jurisdiction

Epithalon vs Related Research Peptides Comparison

Peer-Reviewed References for Epithalon Research

Frequently Researched Alongside Epithalon — Related SourceTides Peptides

Researchers investigating cellular aging, neuroendocrine regulation, and longevity biology often combine Epithalon with the following complementary compounds available from SourceTides:

• BPC-157 research peptide — Tissue repair and gut protection; frequently paired in multi-target longevity protocols
• TB-500 (Thymosin Beta-4) research peptide — Actin regulation, wound healing, and cardiac protection; complementary to Epithalon’s systemic aging research applications
• GHK-Cu (Copper Peptide) research peptide — Antioxidant and gene expression modulation; studied alongside Epithalon in oxidative stress and skin biology research
• Semax research peptide — Russian-origin neuropeptide; BDNF upregulation and neuroprotection; studied alongside Epithalon in neuroendocrine aging protocols
• Thymosin Alpha-1 research peptide — Immune modulation and thymic function; relevant for aging immune system research alongside Epithalon
• Pinealon research peptide — Another pineal-derived bioregulator peptide; studied alongside Epithalon in circadian and neuroendocrine research models

Frequently Asked Questions: Epithalon Peptide 10 mg